Advertisement

Topics

Biotechnology Products Reports

19:42 EDT 16th August 2017 | BioPortfolio

XTL Biopharmaceuticals Ltd XTLB Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryXTL Biopharmaceuticals Ltd XTL is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and formulations. The company's pipeline products comprise hCDR1 peptide and recombinant erythropoietin rHuEPO. Its hCDR1 peptide is used for the treatment of systemic lupus erythematosus SLE; and rHuEPO is a compound developed to prolongate mul...

Venous Leg Ulcers Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

DelveInsight's, Venous Leg Ulcers Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Venous Leg Ulcers. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Venous Leg Ulcers. This report provides information on the therapeutic development for Venous Leg Ulcers, dealing with a...

Global Biosimilars Market Research Report Forecast 2017 to 2022 [Report Updated: 29062017] Prices from USD $2800

Delivery of the Report will take 23 working days once order is placed.The Global Biosimilars Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Biosimilars industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate descriptio...

Febrile Neutropenia Market: By Therapeutics Molecule Type Pegfilgrastim, Vancomycin hydrochloride, Filgrastim biosimilars, Pegfilgrastim biosimilars, Stimuxen and Others By RegionForecast 20162021 [Updated: 29022016] Prices from USD $5250

Febrile neutropenia is the development of fever with sign of infection and is one of the most severe complications during cancer chemotherapy. It is mainly caused by infectious agents such as gram positive and gram negative bacteria. This results in significant reduction of white blood cell count in the patients. Blood test is used to determine the number of white blood cells and to diagnose febri...

Biopharmaceutical Market: By Source Unicellular Multicellular Systems By Products Vaccines, Enzymes, Others Manufacturing Process Single Multi Use Systems Application Oncology, Cardiology, Others End Users Hospitals, OthersForecast20172022 [Updated: 190

Biopharmaceuticals are large and complex products isolated from genetically modified living organisms. Recently, biologics or biopharmaceuticals is one of the fastest growing sectors of pharmaceutical industries, owing to its innovative nature, greater safety and efficacy compared to traditional drugs.The market for Biopharmaceutical is classified into three categories based on source, type of pro...

Northwest Biotherapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 03052017] Prices from USD $350

Northwest Biotherapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Northwest Biotherapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership trans...

Aeglea BioTherapeutics Inc AGLE Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryAeglea BioTherapeutics Inc Aeglea BioTherapeutics, formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company's product pipeline comprises AEB1102, AEB3103, AEB2109, and AEB4104. It develops engineered human enzymes to target and degrade amino acids in t...

Celltrion Inc 068270 Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 16032017] Prices from USD $250

SummaryCelltrion Inc Celltrion is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody bios...

Quick Search
Advertisement
 

review and buy Biotechnology Products market research data and corporate reports here